| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 1,276,710 | 777,504 | 853,069 | 879,439 | | Cost of Revenue | 117,526 | 137,232 | 173,523 | 165,557 | | | Gross Profit | 1,159,184 | 640,272 | 679,546 | 713,882 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 412,391 | 369,319 | 390,625 | 359,513 | | Non Recurring | 41,969 | 716,665 | 242,563 | 115,395 | | Others | 781,433 | 504,901 | 614,131 | 108,151 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (76,609) | (950,613) | (567,773) | 130,823 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (76,609) | (950,613) | (567,773) | 130,823 | | Interest Expense | 26,482 | 27,695 | 43,235 | 78,092 | | Income Before Tax | (103,091) | (978,308) | (611,008) | 52,731 | | Income Tax Expense | (34,239) | (151,727) | (126,512) | 11,214 | | Minority Interest |
-
|
-
| 1,520 | (3,757) | | | | Net Income From Continuing Ops | (68,852) | (826,581) | (482,976) | 37,760 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (68,852) | (826,581) | (482,976) | 37,760 | | Preferred Stock And Other Adjustments | 28,180 | (25,746) | (15,108) | (4,409) | | | Net Income Applicable To Common Shares | ($40,672) | ($852,327) | ($498,084) | $33,351 |
|
2.03% Nasdaq 
Income Statement
